These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12427877)

  • 1. Cognitive impairments in advanced PD without dementia.
    Green J; McDonald WM; Vitek JL; Evatt M; Freeman A; Haber M; Bakay RA; Triche S; Sirockman B; DeLong MR
    Neurology; 2002 Nov; 59(9):1320-4. PubMed ID: 12427877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.
    Hobson P; Meara J
    Mov Disord; 2004 Sep; 19(9):1043-9. PubMed ID: 15372593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study.
    Janvin CC; Aarsland D; Larsen JP
    J Geriatr Psychiatry Neurol; 2005 Sep; 18(3):149-54. PubMed ID: 16100104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Educational level and cognitive impairment in patients with Parkinson disease.
    Kierzynka A; Kaźmierski R; Kozubski W
    Neurol Neurochir Pol; 2011; 45(1):24-31. PubMed ID: 21384290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which factors predict cognitive decline in Parkinson's disease?
    Caparros-Lefebvre D; Pécheux N; Petit V; Duhamel A; Petit H
    J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):51-5. PubMed ID: 7823067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cognitive dysfunction in patients with Parkinson's disease].
    Zakharov VV; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):13-9. PubMed ID: 15704477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A registry-based, case-control investigation of Parkinson's disease with and without cognitive impairment.
    Papapetropoulos S; Ellul J; Polychronopoulos P; Chroni E
    Eur J Neurol; 2004 May; 11(5):347-51. PubMed ID: 15142230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
    Reid WG; Hely MA; Morris JG; Loy C; Halliday GM
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):1033-7. PubMed ID: 21335570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmotor Symptoms and Cognitive Decline in de novo Parkinson's Disease.
    Kwon KY; Kang SH; Kim M; Lee HM; Jang JW; Kim JY; Lee SM; Koh SB
    Can J Neurol Sci; 2014 Sep; 41(5):597-602. PubMed ID: 25373810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDD-Short Screen: a brief cognitive test for screening dementia in Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Martinez-Corral M; Gironell A
    Mov Disord; 2010 Mar; 25(4):440-6. PubMed ID: 20155863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological prediction of dementia in Parkinson's disease.
    Mahieux F; Fénelon G; Flahault A; Manifacier MJ; Michelet D; Boller F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):178-83. PubMed ID: 9489527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
    Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.